section name header

Basic Information ⬇

AUTHORS: Rhinnon E. Chubb, MD, and Tara C. Bouton, MD, MPH, TM

Definition

The intracellular protozoan parasite Cryptosporidium parvum is associated with gastrointestinal diseases, mostly diarrhea and biliary tree disease, especially in patients with AIDS or other immunocompromised hosts. It is also associated with sporadic infections and waterborne outbreaks in immunocompetent hosts. Cryptosporidiosis is a notifiable disease in the U.S.

Other species, including C. hominis, C. felis, C. muris, C. canis, C. suis, and C. meleagridis, are now described to be pathogens as well.

Synonym

Cryptosporidiosis

ICD-10CM CODE
A07.2Cryptosporidiosis
Epidemiology & Demographics
Incidence

  • Approximately 2% of diarrheal illness in industrial countries, 5% to 10% in developing countries.
  • Immunocompromised patients, especially those with HIV/AIDS, are particularly susceptible to infection. 10% to 20% of HIV patients in the United States may excrete cysts.
  • Cryptosporidiosis is a leading cause of all waterborne outbreaks in the U.S. An estimated 823,000 cryptosporidiosis cases occur annually, although fewer than 2% are reported. In 2019, more than 13,000 cases of cryptosporidiosis were reported in the country. The highest incidence was reported in the Midwest.1
Prevalence

Worldwide, especially developing countries; associated with poor hygiene as a waterborne pathogen.

Predominant Sex

Male = female.

Transmission

  • Person-to-person (day care, family members)
  • Animal-to-person (pets, farm animals). Fig. E1 describes the life cycle of Cryptosporidium
  • Environmental (water-associated outbreaks, including travel associated with swimming in or drinking contaminated water or eating contaminated food).
  • May be significant pathogen causing diarrhea in patients with AIDS.

Figure E1 Life cycle of Cryptosporidium.

Oocysts are excreted in the feces. After ingestion, the sporozoites are released from the oocysts and attach to and invade intestinal epithelial cells. The cells engulf the parasites into a parasitophorous vacuole, where they enlarge to form the trophozoites; undergo asexual multiplication, forming type 1 meronts; and release the motile merozoites. The type II meronts differentiate into microgamonts and macrogamonts. The microgametes fertilize the macrogametes to form the zygote. The zygotes develop into the oocysts. Two different types of oocysts are produced: The thick-walled, which is commonly excreted from the host, and the thin-walled, which is primarily involved in autoinfection. Oocysts are infective on excretion, thus permitting direct and immediate fecal-oral transmission.

From Lima AM et al: Cryptosporidiosis. In Guerrant RL et al [eds]: Tropical infectious diseases, ed 3, Philadelphia, 2011, Saunders; Bennett JE et al: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, ed 8, Philadelphia, 2005, Saunders.

Physical Findings & Clinical Presentation

  • Spectrum of illness ranging from asymptomatic to severe enteritis (Table E1). Typical cases in immunocompetent hosts result in self-limited diarrhea, whereas immunocompromised hosts are characterized by profuse, watery, nonbloody diarrhea that may lead to dehydration and weight loss
  • More frequent in children
  • Usually limited to the gastrointestinal tract; however, in individuals with AIDS, the disease may be fulminant and life-threatening (CD4 counts <50)
  • Diarrhea, severe abdominal pain (2 to 28 days)
  • Impaired digestion, dehydration
  • Fever, malaise, fatigue, nausea, vomiting
  • Pneumonia if aspirated

TABLE E1 Clinical Manifestation of Cryptosporidiosis

HostClinical ManifestationsComments
Normal hostAcute watery diarrheaRelapses common
Persistent diarrhea common
Children in developing countriesAcute watery diarrheaDiarrhea more severe in children with malnutrition
Persistent diarrheaPersistent diarrhea affecting nutritional status, growth, and intellectual function
Immunocompromised hostAcute watery diarrheaTransient, self-limited, similar to disease in normal host
Relapsing diarrheaVery common
Persistent or chronic diarrheaUsually found in patients with low CD4 count or malnutrition
Cholera-like illnessVoluminous watery diarrhea, only with very low CD4 count
Extraintestinal involvementRespiratory tract, biliary tract, and pancreas

From Cherry JD et al: Feigin and Cherry’s pediatric infectious diseases, ed 8, Philadelphia, 2019, Elsevier.

Etiology

C. hominis, C. parvum, C. felis, C. muris, C. canis, C. meleagridis, C. suis

Diagnosis ⬆ ⬇

Clinical presentation of acute gastrointestinal illness, especially associated with HIV/AIDS or with travel and waterborne outbreaks

Differential Diagnosis

  • Campylobacter
  • Clostridium difficile
  • Entamoeba histolytica
  • Giardia lamblia
  • Salmonella
  • Shigella
  • Microsporidia
  • Cytomegalovirus
  • Mycobacterium avium
  • Disease may cause cholecystitis, reactive arthritis, hepatitis, urethritis, pancreatitis, or pneumonia in immunocompromised or HIV-infected patients
Workup

  • Stool evaluation looking for characteristic oocyst by modified acid-fast stain (Fig. E2)
  • Direct immunofluorescence using monoclonal antibodies is the gold standard for stool exams
  • Rapid antigen detection
  • Polymerase chain reaction (PCR)
  • HIV antibody testing
  • Liver function tests if biliary involvement suspected
  • Table E2 summarizes diagnostic tests for diagnosing Cryptosporidium infection

TABLE E2 Diagnosis of Cryptosporidium Infection

Test TypeMethodComments
Microscopic examination of stoolsModified acid-fast stain of stoolsInexpensive and widely available diagnostic test
Fluorescent stains (auramine O, auramine-rhodamine)Faster than other acid-fast stains and may improve sensitivity
Immunofluorescent assaysMore sensitive than acid-fast staining but also more expensive
Antigen-detection assaysEnzyme immunoassay and immunochromatographic tests: Direct and indirect immunofluorescence assayGood sensitivity (66%-100%) and excellent specificity (93%-100%), but occasional lots associated with false-positive test results
Molecular methodsPolymerase chain reactionIncreased sensitivity in contrast to microscopic or antigen-detection studies

From Cherry JD et al: Feigin and Cherry’s pediatric infectious diseases, ed 8, Philadelphia, 2019, Elsevier.

Figure E2 Human Stool-Derived Cryptosporidium Oocysts

Excysting Oocyst (Arrow) is Releasing Three of its Four Sporozoites. (Phase-Control Microscopy ×630.)

From Gorbach SL: Infectious diseases, ed 2, Philadelphia, 1998, Saunders.

Treatment ⬆ ⬇

Figure E3 Treatment of cryptosporidiosis.

!!flowchart!!

From Ryan ET: Hunter’s tropical medicine and emerging infectious diseases, ed 10, Philadelphia, 2020, Elsevier.

Disposition

  • A self-limited disease in immunocompetent patients with complete recovery over 2 to 3 wk.
  • In patients with AIDS, chronic infection often clears with initiation and maintenance of antiretroviral therapy.
  • Chronic arthralgia, headache, malaise, and weakness may persist after infection, even in immunologically normal people.
  • If severe and prolonged disease (>30 days), testing for HIV and other immunocompromised states is appropriate, along with a referral to an infectious diseases specialist or gastroenterologist.
Referral

  • To an infectious diseases specialist if symptoms persist and/or HIV infection is found
  • To a gastroenterologist if chronic malabsorption, or biliary or pancreatic complications occur

Pearls & Considerations ⬆ ⬇

Related Content ⬆

  1. Cryptosporidiosis summary reportCDC-Atlanta, 2021.
  1. Centers for Disease Control and Prevention : Cryptosporidiosis summary report, Atlanta, 2019 National Notifiable Disease Surveillance System, Atlanta, 2021, CDC..https://www.cdc.gov/healthywater/surveillance/cryptosporidium/cryptosporidium-2019.html